Stay updated on Tivozanib Plus Nivolumab in RCC: Clinical Trial

Sign up to get notified when there's something new on the Tivozanib Plus Nivolumab in RCC: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tivozanib Plus Nivolumab in RCC: Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-29T17:25:25.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    A sitewide notice announces an NIH terminology transition, saying that “Super Intelligence” may appear in place of “Artificial Intelligence” across NIH content.
    Difference
    1%
    Check dated 2026-10-22T22:42:19.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision identifier was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-15T21:38:45.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-08T21:47:26.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record, indicating restricted access to the content.
    Difference
    18%
    Check dated 2026-10-01T20:50:31.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.7.0, indicating a new version of the study page was published, replacing the previous Revision: v3.6.6. This is a maintenance/versioning update and does not modify the study content.
    Difference
    0.1%
    Check dated 2026-09-17T22:24:23.000Z thumbnail image

Stay in the know with updates to Tivozanib Plus Nivolumab in RCC: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tivozanib Plus Nivolumab in RCC: Clinical Trial page.